FR6764M - - Google Patents

Info

Publication number
FR6764M
FR6764M FR98531A FR98531A FR6764M FR 6764 M FR6764 M FR 6764M FR 98531 A FR98531 A FR 98531A FR 98531 A FR98531 A FR 98531A FR 6764 M FR6764 M FR 6764M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR98531A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR6764M publication Critical patent/FR6764M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR98531A 1966-03-12 1967-03-13 Expired FR6764M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (fr) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
FR6764M true FR6764M (fr) 1969-03-10

Family

ID=19795968

Family Applications (1)

Application Number Title Priority Date Filing Date
FR98531A Expired FR6764M (fr) 1966-03-12 1967-03-13

Country Status (13)

Country Link
US (1) US3534041A (fr)
BE (1) BE695304A (fr)
BR (1) BR6787719D0 (fr)
CH (1) CH501647A (fr)
DE (2) DE1795836C2 (fr)
DK (1) DK124824B (fr)
ES (1) ES337526A1 (fr)
FI (1) FI51694C (fr)
FR (1) FR6764M (fr)
GB (1) GB1173783A (fr)
GR (1) GR37262B (fr)
NL (2) NL6603256A (fr)
SE (1) SE331999B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
GB2091247B (en) * 1980-12-31 1984-07-18 Beecham Group Ltd Pentacyclic compounds processes for their preparation and their use
EP0088575B1 (fr) * 1982-03-05 1986-12-30 Beecham Group Plc Composés pentacycliques
EP0090552A3 (fr) * 1982-03-27 1984-04-25 Beecham Group Plc Composés pentacycliques
EP0126343A1 (fr) * 1983-05-18 1984-11-28 Beecham Group Plc Traitement de la diarrhée
EP0134984B1 (fr) * 1983-07-16 1988-07-13 Beecham Group Plc Dérivés de la benzazépine et de la benzoxazépine
ATE188217T1 (de) * 1987-04-10 2000-01-15 Univ Monash 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
ES2064887T3 (es) 1990-09-13 1995-02-01 Akzo Nobel Nv Composiciones quimicas solidas estabilizadas.
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1017695A4 (fr) * 1997-09-26 2002-01-16 Univ Monash Resolution de composes optiquement actifs
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
CA2537402C (fr) 2003-09-12 2009-05-05 Pfizer Inc. Associations comprenant des ligands alpha-2-delta et des inhibiteurs du recaptage de la serotonine et de la noradrenaline
WO2006060461A1 (fr) 2004-12-03 2006-06-08 Schering Corporation Piperazines substituees en tant qu'antagonistes de cb1
US20070015138A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
CA2625153A1 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
CA2625210A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
CA2637565A1 (fr) 2006-01-18 2007-07-26 Schering Corporation Modulateurs de recepteurs de cannibinoides
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
AU2008271178A1 (en) 2007-06-28 2009-01-08 Intervet International B.V. Substituted piperazines as CB1 antagonists
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010013240A1 (fr) 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions et procédés de traitement de troubles inflammatoires
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
US3534041A (en) 1970-10-13
GB1173783A (en) 1969-12-10
ES337526A1 (es) 1968-03-01
DE1795836C2 (de) 1978-07-20
CH501647A (de) 1971-01-15
BE695304A (fr) 1967-09-11
NL129434C (fr)
DE1695556B2 (de) 1980-10-30
GR37262B (el) 1969-05-10
DE1695556A1 (de) 1972-01-20
DE1695556C3 (de) 1981-06-25
BR6787719D0 (pt) 1973-12-26
SE331999B (fr) 1971-01-25
FI51694B (fr) 1976-11-30
NL6603256A (fr) 1967-09-13
DE1795836B1 (de) 1977-11-24
DK124824B (da) 1972-11-27
FI51694C (fi) 1977-03-10

Similar Documents

Publication Publication Date Title
FI51694B (fr)
AT281852B (fr)
AU1141566A (fr)
AU433222B2 (fr)
AU415165B1 (fr)
AU414526B2 (fr)
AU1144366A (fr)
AU218666A (fr)
AU1393566A (fr)
AU1111066A (fr)
BE686180A (fr)
BE675173A (fr)
BE693388A (fr)
BE693532A (fr)
BE693628A (fr)
BE692267A (fr)
AU1027866A (fr)
BE693952A (fr)
BE692143A (fr)
BE694050A (fr)
AU433620A (fr)
AU2390066A (fr)
AU407778B2 (fr)
AU411645B2 (fr)
BE679538A (fr)